New potent 5-nitroindazole derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and mechanism of action studies

Bioorg Med Chem. 2009 Dec 15;17(24):8186-96. doi: 10.1016/j.bmc.2009.10.030. Epub 2009 Oct 20.

Abstract

New 5-nitroindazole derivatives were developed and their antichagasic properties studied. Eight compounds (14-18, 20, 26 and 28) displayed remarkable in vitro activities against Trypanosoma cruzi (T. cruzi). Its unspecific cytotoxicity against macrophages was evaluated being not toxic at a concentration at least twice that of T. cruzi IC(50), for some derivatives. The electrochemical studies, parasite respiration studies and ESR experiment showed that 5-nitroindazole derivatives not be able to yield a redox cycling with molecular oxygen such as occurs with nifurtimox (Nfx). The study on the mechanism of action proves to be related to the production of reduced species of the nitro moiety similar to that observed with benznidazole.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chagas Disease / drug therapy*
  • Chagas Disease / genetics
  • Crystallography, X-Ray
  • DNA, Protozoan / drug effects*
  • HeLa Cells
  • Humans
  • Indazoles / chemistry
  • Indazoles / pharmacology*
  • Indazoles / therapeutic use
  • Nitroimidazoles / chemical synthesis
  • Nitroimidazoles / pharmacology*
  • Oxidation-Reduction / drug effects
  • Parasitic Sensitivity Tests*
  • Structure-Activity Relationship
  • Trypanocidal Agents / pharmacokinetics
  • Trypanocidal Agents / poisoning*
  • Trypanosoma cruzi / drug effects*

Substances

  • DNA, Protozoan
  • Indazoles
  • Nitroimidazoles
  • Trypanocidal Agents
  • 5-nitroindazole
  • benzonidazole